Morbidity and survival in advanced aids in Rio de Janeiro, Brazil

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 44, Issue 4, 2002, Pages 179-186

  Gadelha, Ângela J ^a   Accacio, Náurea ^b   Costa, Regina L B ^b   Galhardo, Maria Clara ^b   Cotrim, Maria Regina ^b   De Souza, Rogério V ^b   Morgado, Mariza ^a   Marzochi, Keyla ^b   Lourenço, Maria Cristina ^b   Rolla, Valeria C ^b,c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

^c Ctro Pesquisa Hosp Evandro C   (Brazil)

Author keywords

AIDS; CD4 counts; Morbidity; Survival

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; ARTICLE; BLOOD; BRAZIL; CD4 LYMPHOCYTE COUNT; EPIDEMIOLOGY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; INCIDENCE; MIDDLE AGED; MORTALITY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; CD4 LYMPHOCYTE COUNT; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 0036654524     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-46652002000400001     Document Type: Review

References (28)

1. BLUM, S.; SINGH, T.; GIBBONS, J. et al. - Trends in survival among persons with acquired immunodeficiency syndrome in New York City: the experience of the first decade of the epidemic. Amer. J. Epidem., 139: 351-361, 1994.
2. BRODT, H.R.; KAMPS B.S.; GUTE, P. et al. - Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS, 11: 1731-1738, 1997.
3. CAMERON, W.; HEATH-CHIOSI, M.; KRAVICK, S. et al. - Prolongation of life and prevention of AIDS in advanced immunodeficiency with Ritonavir. In: THIRD CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS, Washington, 1996. p. 40.
4. CDC. CENTERS FOR DISEASE CONTROL AND PREVENTION - 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR, 41 (RR-17): 1-19, 1992.
5. CHAISSON, R.E.; KERULY, J.C. & MOORE, R.D. - Race, sex, drug use, and progression of human immunodeficiency virus disease. New Engl. J. Med., 333: 751-756, 1995.
6. CHAISSON, R.E.; GALLANT, J.E.; KERULY, J.C. & MOORE, R.D. - Impact of opportunistic disease on survival in patients with HIV infection. AIDS, 12: 29-33, 1998.
7. DORE, G.; HOY, J.F.; MALLAL, S.A. et al. - Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian cohort. J. AIDS hum. Retrov., 16: 39-43, 1997.
8. FINKELSTEIN, D.M.; WILLIAMS, P.L.; MOLENBERGHS, G. et al. - Patterns of opportunistic infections in patients with HIV infection. J. AIDS hum. Retrov., 12: 38-45, 1996.
9. GADELHA, A.M.J. - Casos notificados de AIDS no Muncípio do Rio de Janeiro, 1983-1993: análise de sobrevida. São Paulo, 1987. (Tese de Doutorado - Universidade de São Paulo).
10. LEDERGERBER, B.; EGGER, M. & TELENTI, A. - AIDS-related opportunistic illness and potent antiretroviral therapy. J. Amer. med. Ass., 283: 2653-2654, 2000.
11. LEMP, G.F; PAYNE, S.F; NEAL, D.; TEMELSO, T. & RUTHERFORD, G.W. - Survival trends for patients with AIDS. J. Amer. med. Ass., 263: 402-406, 1990.
12. LIMA, D.B. - Validação do sistema de estágios proposto pela Organização Mundial de Saúde para infecção e doença pelo HIV em adolescentes e adultos. Rio de Janeiro, Universidade Federal do Rio de Janeiro, 1992.
13. LUO, K.; LAW, M.; KALDOR, J.M.; MCDONALD, A.M. & COOPER, D.A. - The role of initial AIDS-defining illness in survival following AIDS. AIDS, 9: 57-63, 1995.
14. McNAGHTEN, A.D.; HANSON, D.L.; JONES, J.L.; DWORKIN, M.S. & WARD, J.W. - Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group. AIDS, 13: 1687-1695, 1999.
15. MELLORS, J.W.; RINALDO Jr., C.R.; GUPTA, P. et al. - Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science, 272: 1167-1170, 1996.
16. MEZZAROMA, I.; CARLESIMO, M.; PINTER, E. et al. - Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. AIDS, 13: 1187-1193, 1999.
17. MICHELET, C.; ARVIEUX, C.; FRANÇOIS, C. et al. - Opportunistic infections occurring during highly active antiretroviral treatment. AIDS, 12: 1815-1822, 1998.
18. MINISTÉRIO DA SAÚDE, BRASIL - Programa Nacional de Controle de Doenças Sexualmente Transmissíveis/AIDS. Brasília, Ministério da Saúde, 2000. (www.aids.gov.br).
19. + e testes de carga viral: principais marcadores laboratoriais para indicação e monitorização do tratamento anti-retroviral. Brasilia, Unidade de Assistência e Unidade de Laboratório da Coordenação Nacional de DST/AIDS, 1998. v. 2000.
20. MOCROFT, A.J.; JOHNSON, M.A.; SABIN, C.A. et al. - Staging system for clinical AIDS patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. Lancet, 346: 12-17, 1995.
21. MOUTON, Y.; ALFANDARI, S.; VALETTE, M. et al. - Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Federation National des Centres de Lutte contre le SIDA. AIDS, 11: 101-105, 1997.
22. NORÜIIS, M. - Statistical Program for Social Science. Chicago, SPSS, 1995.
23. PALELLA Jr., F.J.; DELANEY, K.M.; MOORMAN, A.C. et al. - Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New Engl. J. Med., 338: 853-860, 1998.
24. PEDERSEN, C.; GERSTOFT, J.; TAURIS, P. et al. - Trends in survival of Danish AIDS patients from 1981 to 1989. AIDS, 4: 1111-1116, 1990.
25. SAAH, A.; HOOVER, D.R.; HE, Y.; KINGSLEY, L. & PHAIR, J.P. - Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS). J. Acquir. Immune Defic. Syndr., 7: 287-295, 1994.
26. SANTORO-LOPES, G.; HARRISON, L.H.; MOULTON, L.H. et al. - Gender and survival after AIDS in Rio de Janeiro, Brazil. J. AIDS hum. Retrov., 19: 403-407, 1998.
27. SCHECHTER, M.T.; CRAIB, K.J; LE, T.N. et al. - Susceptibility to AIDS progression appears early in HIV infection. AIDS, 4: 185-190, 1990.
28. SERC - Statistics and Epidemiology Research Corporation: EGRET. Seattle, User's Manual, 1985.